Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.

This Sirolimus drug-coated balloon (DCB) catheter is poised to revolutionize the treatment of stenotic lesions in Arteriovenous Fistula (AVF) for chronic renal failure patients undergoing ...